Tradestie Institutional Equity Comparison Engine

XOMA vs VIR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XOMA Overall Edge

XOMA Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to XOMA Royalty Corporation Common Stock (XOMA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VIR counters with relative strength in Valuation. Fundamentally, XOMA trades at 21.5x Forward P/E with -3.9% operating margin (-22.6% YoY revenue) versus VIR at 4.3x Forward P/E and -70.2% operating margin (+19582.5% YoY). In options structure, XOMA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against VIR sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VIR
XOMA 21.5x vs VIR 4.3x Fwd P/E
Growth & Margin Winner XOMA
Op Margin -3.9% vs -70.2% ยท YoY -22.6% vs +19582.5%
Momentum & Technical Winner XOMA
1Y +44.0% vs +78.4% ยท 52W Pos 78% vs 49%
Options & Structure Winner XOMA
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (6th %ile IV)
XOMA NASDAQ
XOMA Royalty Corporation Common Stock
Pharmaceutical Preparations
$40.17
-9.16% 1D
Market Cap $781.8M
1M Return -3.81%
1Y Return +43.98%
Forward P/E 21.5x
Unified AI Score
55.8 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 64.0
VIR NASDAQ
Vir Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$9.76
-2.01% 1D
Market Cap $2.1B
1M Return -2.01%
1Y Return +78.43%
Forward P/E 4.3x
Unified AI Score
41.6 / 100 SELL
Tech 20.0 Fund 46.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XOMA +43.98% VIR +78.43% Spread: +53.1 pp (VIR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XOMA TTM Op. Margin: -3.9% VIR TTM Op. Margin: -70.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XOMA vs VIR. Trailing 12-month operating profitability (XOMA -3.9% vs VIR -70.2%) and valuation multiples (XOMA 21.5x vs VIR 4.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XOMA (6) vs VIR (4)
Institutional Metric XOMA VIR Criterion Row Winner
Market Capitalization Scale $781.8M $2.1B Larger Scale VIR
Trailing P/E Ratio Valuation 28.2x 4.3x Lower Multiple VIR
Forward P/E Ratio Valuation 21.5x 4.3x Lower Multiple VIR
Revenue Growth (YoY) Growth -22.6% +19582.5% Higher Growth VIR
Operating Margin (TTM) Profitability -3.9% -70.2% Higher Margin XOMA
Net Profit Margin Profitability 69.6% -61.0% Higher Margin XOMA
Return on Equity (ROE) Capital Efficiency 34.2% -21.8% Higher ROE XOMA
52-Week Range Position Momentum 78% ($22โ€“$45) 49% ($5โ€“$14) Stronger Trend XOMA
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 37% Vol 1.71ฮฒ ยท 102% Vol Lower Realized Risk XOMA
Unified Institutional Score Composite Signal 55.8 / 100 (HOLD) 41.6 / 100 (SELL) Higher Composite XOMA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XOMA vs VIR Buy Guide
XOMA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live XOMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIR BREAKDOWN
5d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VIR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XOMA nor VIR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.